Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Clinical Stage IIA Gastric Cancer AJCC v8
  • Clinical Stage 0 Gastric Cancer AJCC v8
  • Clinical Stage I Gastric Cancer AJCC v8
  • Clinical Stage II Gastric Cancer AJCC v8
  • Clinical Stage IIB Gastric Cancer AJCC v8
  • Clinical Stage III Gastric Cancer AJCC v8
  • Pathologic Stage IIIB Gastric Cancer AJCC v8
  • Pathologic Stage III Gastric Cancer AJCC v8
  • Pathologic Stage IIIC Gastric Cancer AJCC v8
  • Pathologic Stage II Gastric Cancer AJCC v8
  • Gastric Adenocarcinoma
  • Pathologic Stage 0 Gastric Cancer AJCC v8
  • Pathologic Stage IIIA Gastric Cancer AJCC v8
  • Pathologic Stage I Gastric Cancer AJCC v8
  • Pathologic Stage IA Gastric Cancer AJCC v8
  • Pathologic Stage IB Gastric Cancer AJCC v8
  • Pathologic Stage IIA Gastric Cancer AJCC v8
  • Pathologic Stage IIB Gastric Cancer AJCC v8
Type
Observational
Design
Observational Model: Case-OnlyTime Perspective: Prospective

Participation Requirements

Age
Between 18 years and 99 years
Gender
Both males and females

Description

PRIMARY OBJECTIVES: I. Determine how the enhanced recovery after surgery (ERAS) protocol affects patient?s length of hospital stay after radical gastrectomy. II. Determine the association between ambulation (number of steps taken) while hospitalized and complications. III. Determine the association ...

PRIMARY OBJECTIVES: I. Determine how the enhanced recovery after surgery (ERAS) protocol affects patient?s length of hospital stay after radical gastrectomy. II. Determine the association between ambulation (number of steps taken) while hospitalized and complications. III. Determine the association between pre-operatively and postoperatively drawn biochemical markers and complications, disease free survival, and overall survival. OUTLINE: Participants complete standard of care early recovery after surgery protocol beginning the day before surgery to day 6 after surgery. After completion of study, participants are followed up at days 14, 30, 80-110, and 170-200, and at 11-14 months.

Tracking Information

NCT #
NCT03997162
Collaborators
National Cancer Institute (NCI)
Investigators
Principal Investigator: Yanghee Woo City of Hope Medical Center